“In Vivo Inhibitory Effect of Suberoylanilide Hydroxamic Acid Combined With Sorafenib on Human Hepatocellular Carcinoma Cells”. Brazilian Journal of Pharmaceutical Sciences 56 (December 9, 2020): e18254. Accessed May 16, 2024. https://www.revistas.usp.br/bjps/article/view/181441.